…
EMV Capital plc is a venture capital firm specializing in seed, growth capital, early and mid stage investments. The firm focuses to invest in sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, AI and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. It also prefers to invest in companies that significantly improve the health and well-being of people with chronic diseases. Within digital health it focuses on data analytics, wearable technologies, and devices. The firm seeks to invest in companies based in European developed markets, United Kingdom and in the United States. It typically invests up to £15 million ($20.32 million), but may consider larger amounts. It prefers to hold a controlling interest in all principal subsidiaries. The firm prefers to invest through its balance sheet investments. EMV Capital plc was founded on 12 April 2012 and is based in London, United Kingdom with additional office in London, United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | -3.73M | -2.90M | -3.71M | -2.92M | -2.38M |
| Minority interest | 0.66M | 0.26M | 0.58M | 0.48M | - |
| Net income | -3.06M | -2.64M | -3.09M | -2.38M | -1.61M |
| Selling general administrative | 4.01M | 3.96M | 3.72M | 2.57M | 1.99M |
| Gross profit | 2.09M | 1.23M | 0.78M | 0.99M | 0.35M |
| Reconciled depreciation | 0.41M | 0.46M | 0.35M | 0.25M | - |
| Ebit | -3.54M | -2.73M | -3.66M | -2.90M | -2.35M |
| Ebitda | -3.12M | -2.27M | -3.31M | -2.65M | -2.20M |
| Depreciation and amortization | 0.41M | 0.46M | 0.35M | 0.25M | 0.15M |
| Operating income | -3.39M | -2.64M | -3.74M | -2.96M | -2.46M |
| Other operating expenses | 5.84M | 4.08M | 4.74M | 4.07M | 2.86M |
| Interest expense | 0.20M | 0.17M | 0.06M | 0.02M | 0.03M |
| Tax provision | -0.01M | 0.00M | -0.04M | -0.06M | - |
| Interest income | 0.03M | 0.03M | 0.09M | 0.02M | - |
| Net interest income | -0.17M | -0.14M | 0.04M | 0.00M | - |
| Income tax expense | -0.01M | -0.03M | -0.04M | -0.06M | -0.04M |
| Total revenue | 2.45M | 1.45M | 1.00M | 1.11M | 0.39M |
| Total operating expenses | 5.48M | 3.87M | 4.52M | 3.95M | 2.81M |
| Cost of revenue | 0.36M | 0.22M | 0.22M | 0.12M | 0.05M |
| Total other income expense net | -0.35M | -0.26M | 0.03M | 0.04M | 0.08M |
| Net income from continuing ops | -3.72M | -2.90M | -3.67M | -2.86M | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 19.50M | 22.46M | 28.95M | 20.69M | 8.07M |
| Intangible assets | 1.37M | 2.09M | 2.70M | 2.38M | 1.95M |
| Other current assets | 0.22M | 0.23M | 0.46M | 0.53M | 0.69M |
| Total liab | 5.43M | 5.35M | 3.71M | 2.18M | 1.17M |
| Total stockholder equity | 15.10M | 17.83M | 25.84M | 18.50M | 6.74M |
| Other current liab | 2.58M | 1.97M | 1.96M | 1.31M | 0.46M |
| Common stock | 1.37M | 1.18M | 1.17M | 1.06M | 0.75M |
| Capital stock | 1.37M | 1.18M | 1.17M | 1.06M | - |
| Retained earnings | -67.96M | -66.70M | -64.49M | -61.50M | -59.70M |
| Good will | 0.67M | 0.67M | 0.67M | 0.67M | 0.67M |
| Cash | 0.95M | 0.35M | 0.58M | 2.35M | 1.03M |
| Total current liabilities | 4.48M | 3.58M | 2.72M | 1.62M | 0.72M |
| Net debt | 0.59M | 2.19M | 0.67M | -1.70M | -0.53M |
| Short term debt | 0.59M | 0.77M | 0.27M | 0.09M | 0.06M |
| Short long term debt | 0.51M | 0.63M | 0.10M | 0.06M | - |
| Short long term debt total | 1.53M | 2.53M | 1.25M | 0.65M | 0.51M |
| Other stockholder equity | 81.69M | 83.36M | 89.15M | 78.94M | 65.69M |
| Total current assets | 2.07M | 1.35M | 1.59M | 4.38M | 2.08M |
| Net receivables | 0.82M | 0.73M | 0.47M | 1.43M | 0.28M |
| Long term debt | 0.90M | 1.64M | 0.72M | 0.43M | - |
| Inventory | 0.08M | 0.05M | 0.08M | 0.07M | 0.07M |
| Accounts payable | 1.31M | 0.84M | 0.50M | 0.22M | 0.17M |
| Non currrent assets other | - | 17.96M | 23.44M | 12.98M | 3.05M |
| Non current assets total | 17.43M | 21.11M | 27.37M | 16.32M | 5.99M |
| Capital lease obligations | 0.13M | 0.27M | 0.44M | 0.16M | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | 0.20M | 1.48M | -0.48M | -3.40M | - |
| Total cashflows from investing activities | 0.01M | 1.11M | -1.08M | -3.46M | -0.96M |
| Net borrowings | 0.19M | 1.20M | 0.33M | 0.05M | - |
| Total cash from financing activities | 2.57M | 1.39M | 1.74M | 8.02M | 1.89M |
| Net income | -3.72M | -2.90M | -3.67M | -2.86M | -2.34M |
| Change in cash | 0.80M | -0.65M | -1.86M | 1.08M | -1.82M |
| Begin period cash flow | 0.20M | 0.85M | 2.71M | 1.63M | 3.45M |
| End period cash flow | 1.00M | 0.20M | 0.85M | 2.71M | 1.63M |
| Total cash from operating activities | -1.78M | -3.14M | -2.56M | -3.48M | -2.79M |
| Issuance of capital stock | 1.52M | 0.02M | 1.56M | 7.75M | - |
| Depreciation | 0.41M | 0.46M | 0.35M | 0.25M | 0.15M |
| Other cashflows from investing activities | -0.14M | -0.32M | -0.55M | -1.21M | -0.05M |
| Change to inventory | -0.03M | 0.02M | -0.01M | 0.01M | -0.04M |
| Change to account receivables | -0.51M | -0.32M | 0.61M | -1.15M | 0.33M |
| Other cashflows from financing activities | 0.86M | 0.17M | -0.14M | 0.23M | -0.45M |
| Capital expenditures | 0.18M | 0.37M | 0.60M | 0.06M | 0.09M |
| Change in working capital | 0.41M | 0.24M | 1.48M | -0.28M | 0.11M |
| Stock based compensation | 0.06M | 0.07M | 0.11M | 0.14M | 0.05M |
| Other non cash items | 1.05M | -1.01M | -0.82M | -0.72M | -1.44M |
| Free cash flow | -1.97M | -3.51M | -3.16M | -3.54M | -2.88M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| EMVC EMV Capital plc |
1.00 2.44% |
42.00 | - | - | 6.11 | 0.97 | 6.50 | -5.06 |
| MNTN Schiehallion Fund Ltd |
-0.01 0.46% |
2.18 | 0.05 | - | 4.35 | 1.25 | 5.65 | - |
| BHMU BH Macro Limited |
- -% |
4.29 | 0.09 | - | 39.01 | 0.71 | 6.47 | - |
| TFG Tetragon Financial Group Ltd |
0.15 1.00% |
15.10 | 0.02 | 7.04 | 1.16 | 0.31 | 2.06 | 6.56 |
| BPCR BioPharma Credit PLC |
0.00 0.41% |
0.98 | 0.09 | - | 6.73 | 0.91 | 7.95 | - |
EMV Capital plc is a venture capital firm specializing in seed, growth capital, early and mid stage investments. The firm focuses to invest in sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, AI and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. It also prefers to invest in companies that significantly improve the health and well-being of people with chronic diseases. Within digital health it focuses on data analytics, wearable technologies, and devices. The firm seeks to invest in companies based in European developed markets, United Kingdom and in the United States. It typically invests up to £15 million ($20.32 million), but may consider larger amounts. It prefers to hold a controlling interest in all principal subsidiaries. The firm prefers to invest through its balance sheet investments. EMV Capital plc was founded on 12 April 2012 and is based in London, United Kingdom with additional office in London, United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Dr. Ilian Petkov Iliev | CEO & Director | 1975 |
| Mr. Edward Benjamin Peter Hooper | Executive Director, General Counsel & Group Company Secretary | 1979 |
| Mr. Aneshkumar Ishwarbhai Patel C.A. | Group Chief Financial Officer & Secretary | 1981 |
| Mr. Tom Rudd | Business Development Manager (EIS Fund) | NA |
| Mr. Stephen Daniel Crowe | Portfolio Chief Financial Officer & Secretary | NA |
| Mr. Harry Miller | Head of Research | NA |
| Mr. Nick Salisbury | Head of Capital Raising & Co-Investment | NA |
| Ms. Hannah Jarvis | Financial Controller | NA |
| Mr. Tom Hall | Investment Director | NA |
| Mr. John Eric Clarkson | Venture Partner of Industrials | 1950 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.